Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Astria Therapeutics, Inc. (ATXS) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/19/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/15/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
02/03/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/01/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
02/01/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/12/2020 3 Harshbarger Benjamin (Secretary and General Counsel) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
12/19/2019 3 Clauser Noah (Vice President, Finance) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
09/19/2019 3 Komjathy Andrew (Chief Commercial Officer) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
07/30/2019 3 Cole Hugh M (Director) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
02/15/2019 3 Beck Joanne T. (Director) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
01/04/2019 3 LAPOINTE ANTHONY GREGG (Director) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
02/17/2017 3 Hibben Edward K. (Chief Business Officer) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
10/05/2016 3 Nichols Andrew John (Chief Scientific Officer) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
04/07/2016 3 KISHBAUCH MICHAEL D (Director) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
04/07/2016 3 ADELMAN BURT A (Director) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy